A new meeting report was published in Volume 18 of Aging-US on April 6, 2026, titled “Toward actionable interventions in ...

Security is all too often treated as a purely compliance-driven exercise. This isn’t advisable in any industry, but it is ...

OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the ...

In a single day, major tech firms, startups, and researchers unveiled significant AI-driven advances in drug discovery, from protein interaction models to enterprise-wide AI integration in pharma.

As SaaS companies shift to usage-based and hybrid pricing, the ARR underpinning billions in venture debt grows harder to ...